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The network of cells and soluble mediators implicated in the pathogenesis of asthma and 
allergic disorders is complex. Deciphering details of the crosstalk between its components is 
essential for the identification of novel drug targets and for advances in patient management 
and precision medicine (1, 2). There is increasing evidence that innate lymphoid cells (ILCs) 
contribute to allergic responses (3). ILCs represent subsets of lymphocytes that express 
distinct patterns of cytokines and, similar to T and B cells, arise from a common lymphoid 
progenitor (CLP) cell (4). Given that natural killer (NK) cells, the prototypical member of the 
ILC family (4), express Fc-receptors, their activity depends on the composition of the 
individual antibody repertoire (5, 6), but is also tightly balanced by activating and inhibitory 
receptors (7). NK cell inhibitory receptors are specific for MHC class I, whereas others 
recognize non-MHC protein or glycan ligands (7, 8). Furthermore, Massi et al. reported that 
endogenous cannabinoids inhibit NK cell activity by engagement of the G protein-coupled 
cannabinoid receptors CB1 and CB2 (9). In contrast to NK cells, which have been classified 
as group 1 ILC, group 2 innate lymphoid cells (ILC2) are characterized by the production of 
T helper 2 (TH2) cell-associated cytokines (3), and increasing evidence demonstrates their 
contribution to allergic disorders, including asthma (reviewed in (4)). Recently, increased 
numbers of ILC2 cells in mucosal samples of patients with chronic rhinosinusitis (CRS) were 
shown to correlate with TH2 cell frequency (10), supporting the notion that interactions 
between ILC2 cells and the adaptive immune system might take place during allergic 
inflammation (4). Does crosstalk also exist between ILC subsets such as NK cells and ILC2 
in allergic inflammation and by what factors would it be influenced? 
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In the current issue of Allergy, Ferrini et al. (11) provide evidence suggesting a role of 
NK cells in limiting ILC2 responses and subsequent allergic airway inflammation depending 
on NK cell regulation by CB2. Intranasal exposure to house dust mite (HDM) allergen led to 
reduced allergic airway inflammation in CB2-/- mice, a finding that was also observed when 
WT animals were treated with the CB2-specific antagonist AM630. Interestingly, CB2-/- mice 
displayed elevated numbers of NK cells in the lungs, which was inversely correlated with 
ILC2 frequency. Depletion of NK cells in CB2-/- mice restored airway inflammation and was 
associated with increased ILC2 numbers in the lung. To confirm a regulatory effect of 
endocannabinoids on NK cell activation (9), in the present study NK cells were stimulated 
with anti-NK1.1 antibody obtaining a dose dependent inhibition of IFN-γ production by 
endocannabinoid 2-arachidonyl-glycerol (2-AG). Notably, adoptive transfer of CB2-/-NK cells 
into WT hosts suppressed HDM-induced airway inflammation, suggesting that NK cells 
unrestrained by endogenous CB2 stimulation may act as gatekeepers to limit allergen 
responsiveness, eventually by mechanisms that include the regulation of allergy-promoting 
ILC2 cells. 
 
Early studies in the seventies revealed a beneficial effect of inhaled or orally taken 
cannabinoids by dilating bronchial smooth muscles (12, 13). Since then, both anti- and pro-
inflammatory effects of endocannabinoids have been reported, which has been attributed, in 
part, to bioactive metabolites and signalling by additional receptors, aside from CB1 and 
CB2, which are both expressed on human leukocytes (14). Several studies using mice 
lacking the CB2 receptor have shown exacerbated inflammation in different disease models 
(15). In contrast, Ferrini et al. (11) demonstrate in the HDM-induced asthma model using 
CB2-/- mice that CB2 augments allergen responsiveness. Interestingly, an allergy promoting 
role of CB2 was also observed in an ear dermatitis model with CB2-/- mice (16), and by the 
use of the CB2 receptor agonist JWH-133 in a OVA-induced asthma model with C57BL6 
mice showing a direct effect of CB2 on eosinophil responses (17). This raises the question if 
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the immunomodulatory role of CB2 may depend on the type of immune response (e.g. 
allergic versus non-allergic). Further studies will be required to address this question or to 
exclude potential confounding variables, e.g. related to the disease model or mouse strain 
used (18, 19). In this regard, abnormalities in the development of several lymphocyte 
subsets have been reported in CB2-/- mice (20). 
The finding by Ferrini et al. (11) that NK cells may control ILC2 cells in allergic 
responses is intriguing. The exact mechanisms remain to be explored, but may include 
effects of NK cell-derived cytokines, such as IFN-γ (21), or other divergent strategies that NK 
cells employ for the control of immune cells (22). Given that NK cells are implicated in 
immune responses to viruses, the findings by Ferrini et al. (11) might indicate a potential 
mechanistic link between viral infection and TH2-biased allergic airway disease (23). 
Furthermore, altered frequencies and functions of NK cells in asthma patients have 
previously been reported (24, 25). The study by Ferrini et al. (11) highlights the need to 
explore cellular networks including ILC cells in different individuals and phenotypes of 
allergic diseases to better understand these disorders at the clinical and mechanistic level 
(26). 
 
References 
1. von Gunten S, Cortinas-Elizondo F, Kollarik M, Beisswenger C, Lepper PM. Mechanisms and 
potential therapeutic targets in allergic inflammation: recent insights. Allergy 2013;68:1487-1498. 
2. Muraro A, Fokkens WJ, Pietikainen S, Borrelli D, Agache I, Bousquet J, et al. European 
symposium on precision medicine in allergy and airways diseases: report of the European Union 
parliament symposium (October 14, 2015). Rhinology 2015;53:303-307. 
3. Licona-Limon P, Kim LK, Palm NW, Flavell RA. TH2, allergy and group 2 innate lymphoid cells. 
Nat Immunol 2013;14:536-542. 
4. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells--a 
proposal for uniform nomenclature. Nat Rev Immunol 2013;13:145-149. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
5. Schneider C, Smith DF, Cummings RD, Boligan KF, Hamilton RG, Bochner BS, et al. The 
human IgG anti-carbohydrate repertoire exhibits a universal architecture and contains specificity for 
microbial attachment sites. Sci Transl Med 2015;7:269ra261. 
6. Pashova S, Schneider C, von Gunten S, Pashov A. Antibody Repertoire Profiling with 
Mimotope Arrays. Hum Vaccin Immunother; in press. 
7. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 
2008;9:495-502. 
8. Jandus C, Boligan KF, Chijioke O, Liu H, Dahlhaus M, Demoulins T, et al. Interactions between 
Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. J Clin 
Invest 2014;124:1810-1820. 
9. Massi P, Fuzio D, Vigano D, Sacerdote P, Parolaro D. Relative involvement of cannabinoid 
CB(1) and CB(2) receptors in the Delta(9)-tetrahydrocannabinol-induced inhibition of natural killer 
activity. Eur J Pharmacol 2000;387:343-347. 
10. Miljkovic D, Bassiouni A, Cooksley C, Ou J, Hauben E, Wormald PJ, et al. Association between 
group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis. Allergy 
2014;69:1154-1161. 
11. Ferrini ME, Hong S, Stierle A, Stierle D, Stella N, Roberts K, et al. CB2 receptors regulate 
natural killer cells that limit allergic airway inflammation in a murine model of asthma. Allergy 
2017;ADD SAME ISSUE (EDITORIAL ON THIS ARTICLE). 
12. Tashkin DP, Reiss S, Shapiro BJ, Calvarese B, Olsen JL, Lodge JW. Bronchial effects of 
aerosolized delta 9-tetrahydrocannabinol in healthy and asthmatic subjects. Am Rev Respir Dis 
1977;115:57-65. 
13. Abboud RT, Sanders HD. Effect of oral administration of delta-tetrahydrocannabinol on 
airway mechanics in normal and asthmatic subjects. Chest 1976;70:480-485. 
14. Turcotte C, Chouinard F, Lefebvre JS, Flamand N. Regulation of inflammation by 
cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and 
their metabolites. J Leukoc Biol 2015;97:1049-1070. 
15. Turcotte C, Blanchet MR, Laviolette M, Flamand N. The CB2 receptor and its role as a 
regulator of inflammation. Cell Mol Life Sci 2016;73:4449-4470. 
16. Mimura T, Oka S, Koshimoto H, Ueda Y, Watanabe Y, Sugiura T. Involvement of the 
endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation. Int Arch Allergy 
Immunol 2012;159:149-156. 
17. Frei RB, Luschnig P, Parzmair GP, Peinhaupt M, Schranz S, Fauland A, et al. Cannabinoid 
receptor 2 augments eosinophil responsiveness and aggravates allergen-induced pulmonary 
inflammation in mice. Allergy 2016;71:944-956. 
18. von Gunten S, Shoenfeld Y, Blank M, Branch DR, Vassilev T, Kasermann F, et al. IVIG 
pluripotency and the concept of Fc-sialylation: challenges to the scientist. Nat Rev Immunol 
2014;14:349. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
19. Quast I, Keller CW, Weber P, Schneider C, von Gunten S, Lunemann JD. Protection from 
experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced 
inflammation. J Neuroinflammation 2016;13:42. 
20. Ziring D, Wei B, Velazquez P, Schrage M, Buckley NE, Braun J. Formation of B and T cell 
subsets require the cannabinoid receptor CB2. Immunogenetics 2006;58:714-725. 
21. Moro K, Kabata H, Tanabe M, Koga S, Takeno N, Mochizuki M, et al. Interferon and IL-27 
antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses. Nat 
Immunol 2016;17:76-86. 
22. Crouse J, Xu HC, Lang PA, Oxenius A. NK cells regulating T cell responses: mechanisms and 
outcome. Trends Immunol 2015;36:49-58. 
23. Lan F, Zhang N, Gevaert E, Zhang L, Bachert C. Viruses and bacteria in Th2-biased allergic 
airway disease. Allergy 2016;71:1381-1392. 
24. Lin SJ, Chang LY, Yan DC, Huang YJ, Lin TJ, Lin TY. Decreased intercellular adhesion molecule-
1 (CD54) and L-selectin (CD62L) expression on peripheral blood natural killer cells in asthmatic 
children with acute exacerbation. Allergy 2003;58:67-71. 
25. Jira M, Antosova E, Vondra V, Strejcek J, Mazakova H, Prazakova J. Natural killer and 
interleukin-2 induced cytotoxicity in asthmatics. I. Effect of acute antigen-specific challenge. Allergy 
1988;43:294-298. 
26. Bousquet J, Anto JM, Akdis M, Auffray C, Keil T, Momas I, et al. Paving the way of systems 
biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the 
Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015. Allergy 2016;71:1513-1525. 
 
Figures 
 
Figure 1 Putative role of NK cells as gatekeepers of the allergic party, which may involve the 
control of allergy-promoting ILC2 cells. The NK cell gatekeeper’s attention is impaired by 
signalling through the cannabinoid receptor CB2 (left panel), and enhanced in absence of 
CB2, represented as broken cannabis pipe in the cartoon (right panel). Illustration by Aldona 
von Gunten.  
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